NFlection Therapeutics
nflection.comLocations
Boston, MA, USA · West Street / River Street, Boston, MA, USA
industry
Biotechnology
Size
1 - 10 employees
Stage
Series B
founded in
2014
Inflection is a biopharmaceutical company focused on the development of novel therapies to address the needs of patients with Neurofibromatosis Type 1, immunosuppressant-mediated Squamous Cell Carcinoma, and congenital birthmarks such as Keratinocytic Epidermal Nevi. To address these RAS-mediated disorders, driven by the aberrant activation of the RAS/RAF/MEK/ERK pathway, we are developing first-in-class MEK (Mitogen-Activated Protein Kinase Kinase) inhibitors as topical treatments.
Something looks off?Open jobs at NFlection Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.